Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Biodesix, Inc. operates as a data-driven diagnostic solutions company in the United States. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests, together marketed as part of Nodify Lung Nodule Risk Assessment testing strategy, to assess the risk of lung cancer and help in identifying the appropriate treatment pathway and help physicians in reclassifying risk of malignancy in patients with suspicious lung nodules. It also provides GeneStrat ddPCR and NGS, and VeriStrat tests, which are used in the diagnosis of lung cancer to measure the presence of mutations in the tumor and the state of the patient's immune system to establish the patient's prognosis and help guide treatment decisions. In addition, the company, through its partnership with Bio-Rad Laboratories, Inc., provides Bio-Rad SARS-CoV-2 ddPCR, a COVID-19 Test under Biodesix WorkSafe testing program; and Platelia SARS-CoV-2 Total Ab test, an antibody test for detecting a B-cell immune response to SARS-CoV-2 that indicate recent or prior infection. Further, it offers diagnostic and clinical research, as well as clinical trial testing services to biopharmaceutical companies; and discovers, develops, and commercializes companion diagnostics. The company was formerly known as Elston Technologies, Inc. and as changed to Biodesix, Inc. in 2006. Biodesix, Inc. was incorporated in 2005 and is headquartered in Louisville, Colorado. more
Time Frame | BDSX | Sector | S&P500 |
---|---|---|---|
1-Week Return | 3.08% | -2.06% | -0.55% |
1-Month Return | 6.35% | -1.92% | 2.72% |
3-Month Return | -22.99% | -10.4% | 7.66% |
6-Month Return | -16.77% | -4.6% | 10.15% |
1-Year Return | -19.28% | 4.06% | 27.53% |
3-Year Return | -69.61% | 1.94% | 32.31% |
5-Year Return | -89.54% | 36.48% | 89.2% |
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | 24.55M | 45.56M | 54.51M | 38.21M | 49.09M | [{"date":"2019-12-31","value":45.04,"profit":true},{"date":"2020-12-31","value":83.58,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":70.11,"profit":true},{"date":"2023-12-31","value":90.06,"profit":true}] |
Cost of Revenue | 6.07M | 22.00M | 30.52M | 14.15M | 13.01M | [{"date":"2019-12-31","value":19.9,"profit":true},{"date":"2020-12-31","value":72.08,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":46.38,"profit":true},{"date":"2023-12-31","value":42.63,"profit":true}] |
Gross Profit | 18.48M | 23.56M | 23.99M | 24.06M | 36.08M | [{"date":"2019-12-31","value":51.22,"profit":true},{"date":"2020-12-31","value":65.3,"profit":true},{"date":"2021-12-31","value":66.49,"profit":true},{"date":"2022-12-31","value":66.69,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Gross Margin | 75.26% | 51.71% | 44.01% | 62.96% | 73.50% | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":68.71,"profit":true},{"date":"2021-12-31","value":58.48,"profit":true},{"date":"2022-12-31","value":83.65,"profit":true},{"date":"2023-12-31","value":97.66,"profit":true}] |
Operating Expenses | 41.10M | 45.67M | 63.31M | 74.56M | 77.42M | [{"date":"2019-12-31","value":53.09,"profit":true},{"date":"2020-12-31","value":59,"profit":true},{"date":"2021-12-31","value":81.77,"profit":true},{"date":"2022-12-31","value":96.31,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Operating Income | (22.63M) | (22.12M) | (39.32M) | (50.51M) | (41.34M) | [{"date":"2019-12-31","value":-2262700000,"profit":false},{"date":"2020-12-31","value":-2211600000,"profit":false},{"date":"2021-12-31","value":-3931800000,"profit":false},{"date":"2022-12-31","value":-5050600000,"profit":false},{"date":"2023-12-31","value":-4134200000,"profit":false}] |
Total Non-Operating Income/Expense | (11.05M) | (16.00M) | (6.73M) | (22.93M) | (20.56M) | [{"date":"2019-12-31","value":-1105200000,"profit":false},{"date":"2020-12-31","value":-1600200000,"profit":false},{"date":"2021-12-31","value":-672700000,"profit":false},{"date":"2022-12-31","value":-2293200000,"profit":false},{"date":"2023-12-31","value":-2056100000,"profit":false}] |
Pre-Tax Income | (30.73M) | (31.35M) | (43.16M) | (65.45M) | (52.15M) | [{"date":"2019-12-31","value":-3072600000,"profit":false},{"date":"2020-12-31","value":-3135000000,"profit":false},{"date":"2021-12-31","value":-4315900000,"profit":false},{"date":"2022-12-31","value":-6544700000,"profit":false},{"date":"2023-12-31","value":-5214600000,"profit":false}] |
Income Taxes | 629.00K | 5.12M | 1.32M | 14.94M | 5.34M | [{"date":"2019-12-31","value":4.21,"profit":true},{"date":"2020-12-31","value":34.29,"profit":true},{"date":"2021-12-31","value":8.84,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":35.73,"profit":true}] |
Income After Taxes | (31.36M) | (36.47M) | (44.48M) | (80.39M) | (57.49M) | [{"date":"2019-12-31","value":-3135500000,"profit":false},{"date":"2020-12-31","value":-3647300000,"profit":false},{"date":"2021-12-31","value":-4448000000,"profit":false},{"date":"2022-12-31","value":-8038800000,"profit":false},{"date":"2023-12-31","value":-5748510500,"profit":false}] |
Income From Continuous Operations | (30.73M) | (31.35M) | (43.16M) | (65.45M) | (63.34M) | [{"date":"2019-12-31","value":-3072600000,"profit":false},{"date":"2020-12-31","value":-3135000000,"profit":false},{"date":"2021-12-31","value":-4315900000,"profit":false},{"date":"2022-12-31","value":-6544700000,"profit":false},{"date":"2023-12-31","value":-6334500000,"profit":false}] |
Income From Discontinued Operations | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Net Income | (31.36M) | (36.47M) | (44.48M) | (80.39M) | (52.15M) | [{"date":"2019-12-31","value":-3135500000,"profit":false},{"date":"2020-12-31","value":-3647300000,"profit":false},{"date":"2021-12-31","value":-4448000000,"profit":false},{"date":"2022-12-31","value":-8038800000,"profit":false},{"date":"2023-12-31","value":-5214600000,"profit":false}] |
EPS (Diluted) | - | (32.45) | (1.54) | (1.59) | (0.65) | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-3245.5,"profit":false},{"date":"2021-12-31","value":-154,"profit":false},{"date":"2022-12-31","value":-159,"profit":false},{"date":"2023-12-31","value":-65,"profit":false}] |
These ratios help you determine the liquidity of the company. Higher is better.
BDSX | |
---|---|
Cash Ratio | 2.42 |
Current Ratio | 3.40 |
Quick Ratio | 3.30 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
BDSX | |
---|---|
ROA (LTM) | -22.79% |
ROE (LTM) | -331.82% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
BDSX | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 0.73 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.27 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
BDSX | |
---|---|
Trailing PE | NM |
Forward PE | NM |
P/S (TTM) | 3.08 |
P/B | 7.26 |
Price/FCF | NM |
EV/R | 3.55 |
EV/Ebitda | NM |
Biodesix Inc (BDSX) share price today is $1.34
Yes, Indians can buy shares of Biodesix Inc (BDSX) on Vested. To buy Biodesix Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in BDSX stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of Biodesix Inc (BDSX) via the Vested app. You can start investing in Biodesix Inc (BDSX) with a minimum investment of $1.
You can invest in shares of Biodesix Inc (BDSX) via Vested in three simple steps:
The 52-week high price of Biodesix Inc (BDSX) is $2.21. The 52-week low price of Biodesix Inc (BDSX) is $1.11.
The price-to-earnings (P/E) ratio of Biodesix Inc (BDSX) is
The price-to-book (P/B) ratio of Biodesix Inc (BDSX) is 7.26
The dividend yield of Biodesix Inc (BDSX) is 0.00%
The market capitalization of Biodesix Inc (BDSX) is $202.20M
The stock symbol (or ticker) of Biodesix Inc is BDSX